(RTTNews) - Medical technology company TELA Bio, Inc. (TELA) announced Monday that its Liora Monofilament Scaffold product was granted 510(k) clearance by the U.S. Food and Drug Administration.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
TELA Bio Says FDA Grants 510(k) Clearance For Liora Monofilament Scaffold Product
